Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Tal Yalon, M.D., Mayo Clinic
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Thyroid & Parathyroid Surgery: Ask Mayo Clinic Health System
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Mike Novogratz on the Intuition and Luck Behind Global Macro Trading
00:00:00
Francois Martelet, CEO, Oasmia Pharmaceutical
00:10:00
Stifel CEO Ron Kruszewski Discusses Market Outlook and AI Impact at Blueprint Conference | Ronald J Kruszewski, CEO , Stifel Financial Corp.
00:10:00
"Mastering Investment Decisions in 2024: Insights with Caspar Berry | Schroders Investor Download Podcast"
00:10:00
BigCommerce CEO Brent Bellm on the company's IPO | Brent Bellm, CEO, Bigcommerce Holdings Inc (NASDAQ: BIGC)
00:10:00
We're seed specialists that partner with founders at the earliest stages to turn great ideas into category-defining companies|Mar Hershenson,Founding Managing Partner, Pear Ventures
00:10:00
Unlocking Tomorrow's Opportunities: Teo Dechev's Insights at the 2023 Rule Symposium | Teo Dechev - CEO of Mundoro Capital Inc.
00:10:00
help achieve our mission of Transforming the Moving World|Cyrus Sigari, Managing Partner,UP Partners
00:00:00
Soligenix Inc is a late-stage biopharmaceutical company - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:10:00
Rafaela Resources: Developing Critical Metals Projects in Spain and Canada
00:10:00
Leadership Perspectives on Investor Protection and Risk Management | Tim Buckley, CEO , Vanguard .
00:10:00
Joel Simkins, Managing Director at Houlihan Lokey, and Lei Zhang, Founder and CEO of Hillhouse Capital, discuss industry trends alongside Goldman Sachs.